Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care.

Hayes P, Casey M, Glynn LG, Molloy GJ, Durand H, O'Brien E, Dolan E, Das K, Newell J, Finn D, Harhen B, Conneely A, Murphy AW.

Br J Gen Pract. 2019 Jul 29. pii: bjgp19X705077. doi: 10.3399/bjgp19X705077. [Epub ahead of print]

PMID:
31358495
2.

Medication adherence for resistant hypertension: Assessing theoretical predictors of adherence using direct and indirect adherence measures.

Durand H, Hayes P, Harhen B, Conneely A, Finn DP, Casey M, Murphy AW, Molloy GJ.

Br J Health Psychol. 2018 Nov;23(4):949-966. doi: 10.1111/bjhp.12332. Epub 2018 Jul 16.

PMID:
30014548
3.

Plasma N-acylethanolamine and endocannabinoid levels in burning mouth syndrome: Potential role in disease pathogenesis.

Barry A, O'Halloran KD, McKenna JP, McCreary C, Harhen B, Kerr DM, Finn DP, Downer EJ.

J Oral Pathol Med. 2018 Apr;47(4):440-442. doi: 10.1111/jop.12692. Epub 2018 Mar 2.

PMID:
29436743
4.

Characterisation of peroxisome proliferator-activated receptor signalling in the midbrain periaqueductal grey of rats genetically prone to heightened stress, negative affect and hyperalgesia.

Okine BN, Gaspar JC, Madasu MK, Olango WM, Harhen B, Roche M, Finn DP.

Brain Res. 2017 Feb 15;1657:185-192. doi: 10.1016/j.brainres.2016.11.022. Epub 2016 Dec 1.

PMID:
27916440
5.

N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism.

Okine BN, Madasu MK, McGowan F, Prendergast C, Gaspar JC, Harhen B, Roche M, Finn DP.

Pain. 2016 Dec;157(12):2687-2696.

PMID:
27649266
6.

Ptaquiloside in Irish Bracken Ferns and Receiving Waters, with Implications for Land Managers.

O'Driscoll C, Ramwell C, Harhen B, Morrison L, Clauson-Kaas F, Hansen HC, Campbell G, Sheahan J, Misstear B, Xiao L.

Molecules. 2016 Apr 26;21(5). pii: E543. doi: 10.3390/molecules21050543.

7.

Involvement of the endocannabinoid system in attentional modulation of nociceptive behaviour in rats.

Ford GK, Moriarty O, Okine BN, Tully E, Mulcahy A, Harhen B, Finn DP.

Eur J Pain. 2015 Sep;19(8):1177-85. doi: 10.1002/ejp.646. Epub 2014 Dec 15.

PMID:
25504741
8.

Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.

Rea K, Ford GK, Olango WM, Harhen B, Roche M, Finn DP.

Eur J Neurosci. 2014 Feb;39(3):435-43. doi: 10.1111/ejn.12452.

PMID:
24494683
9.

Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype-dependent hyper-responsivity to noxious stimuli.

Rea K, Olango WM, Okine BN, Madasu MK, McGuire IC, Coyle K, Harhen B, Roche M, Finn DP.

Pain. 2014 Jan;155(1):69-79. doi: 10.1016/j.pain.2013.09.012. Epub 2013 Sep 25.

PMID:
24076311
10.

Cdc7-dependent and -independent phosphorylation of Claspin in the induction of the DNA replication checkpoint.

Rainey MD, Harhen B, Wang GN, Murphy PV, Santocanale C.

Cell Cycle. 2013 May 15;12(10):1560-8. doi: 10.4161/cc.24675. Epub 2013 Apr 17.

11.

Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats.

Rea K, Olango WM, Harhen B, Kerr DM, Galligan R, Fitzgerald S, Moore M, Roche M, Finn DP.

Pain. 2013 Apr;154(4):576-85. doi: 10.1016/j.pain.2012.12.021. Epub 2012 Dec 31.

PMID:
23414578
12.

The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.

Kerr DM, Harhen B, Okine BN, Egan LJ, Finn DP, Roche M.

Br J Pharmacol. 2013 Jun;169(4):808-19. doi: 10.1111/j.1476-5381.2012.02237.x.

13.

DNA mediated chromatin pull-down for the study of chromatin replication.

Kliszczak AE, Rainey MD, Harhen B, Boisvert FM, Santocanale C.

Sci Rep. 2011;1:95. doi: 10.1038/srep00095. Epub 2011 Sep 19.

14.

Cross validation of liquid chromatography-mass spectrometry and lectin array for monitoring glycosylation in fed-batch glycoprotein production.

Hayes CA, Doohan R, Kirkley D, Leister K, Harhen B, Savage AV, Karlsson NG.

Mol Biotechnol. 2012 Jul;51(3):272-82. doi: 10.1007/s12033-011-9465-8.

PMID:
22048797
15.

Negative ion CID fragmentation of O-linked oligosaccharide aldoses--charge induced and charge remote fragmentation.

Doohan RA, Hayes CA, Harhen B, Karlsson NG.

J Am Soc Mass Spectrom. 2011 Jun;22(6):1052-62. doi: 10.1007/s13361-011-0102-3. Epub 2011 Mar 31.

PMID:
21953046
16.

Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor.

Kerr DM, Burke NN, Ford GK, Connor TJ, Harhen B, Egan LJ, Finn DP, Roche M.

Neuroscience. 2012 Mar 1;204:53-63. doi: 10.1016/j.neuroscience.2011.09.032. Epub 2011 Sep 19.

PMID:
21952131
17.

A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats.

Ford GK, Kieran S, Dolan K, Harhen B, Finn DP.

Pain. 2011 Nov;152(11):2495-504. doi: 10.1016/j.pain.2011.07.014. Epub 2011 Aug 23.

PMID:
21864979
18.

The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.

Olango WM, Roche M, Ford GK, Harhen B, Finn DP.

Br J Pharmacol. 2012 Apr;165(8):2549-60. doi: 10.1111/j.1476-5381.2011.01478.x.

19.

Nimesulide 90 mg orally twice daily does not influence postoperative morphine requirements after major chest surgery.

Harney DF, Dooley M, Harhen B, McGuiness N, Cagney G, McCrory C, Fitzgerald DJ, Dowd NP.

Anesth Analg. 2008 Jan;106(1):294-300, table of contents. doi: 10.1213/01.ane.0000289528.87796.0b.

PMID:
18165593
20.

Profound resolution of early atherosclerosis with conjugated linoleic acid.

Toomey S, Harhen B, Roche HM, Fitzgerald D, Belton O.

Atherosclerosis. 2006 Jul;187(1):40-9. Epub 2005 Sep 22.

PMID:
16182300
21.

Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS.

Perneby C, Granström E, Beck O, Fitzgerald D, Harhen B, Hjemdahl P.

Thromb Res. 1999 Dec 15;96(6):427-36.

PMID:
10632465
22.

Immobilization of proteolytic enzymes.

Harhen B, Barry F.

Biochem Soc Trans. 1990 Apr;18(2):314-5. No abstract available.

PMID:
2199269

Supplemental Content

Loading ...
Support Center